• Sep 15, 2026

  $86.45+2.09%

  DexCom shares rose 2.09%, outpacing comparable surgical and medical instrument companies, which moved just +0.58% on average that day [1]. The gain came on volume 1.6 times the trailing average, with the stock trading between 83.25 and 87.36 during the session [2].

  • 1Peer group
  • 2Market data

• Sep 14, 2026

  $84.68+1.99%

  DexCom shares rose 1.99%, a move that came alongside a broader advance among comparable surgical and medical instrument companies, which rose 2.55% on average with all six names higher [1].

  • 1Peer group

• Sep 11, 2026

  $83.03-1.75%

  DXCM shares fell 1.75% on a day when comparable surgical and medical instruments companies were little changed, moving +0.12% on average [1]. The decline was not shared by that peer group, which was split evenly between gainers and decliners [1].

  • 1Peer group

• Sep 10, 2026

  $84.51+0.75%

  DXCM rose 0.75% even as comparable surgical and medical instrument companies fell 1.92% on average [1]. The gain came despite most peers in that group declining [1].

  • 1Peer group

• Sep 9, 2026

  $83.88-0.77%

• Sep 8, 2026

  $84.53-3.83%

  Comparable surgical and medical instrument companies fell 3.29% on average, with all six names in the group declining [1]. Trading volume was elevated at 2.0x the trailing average for the session [2].

  • 1Peer group
  • 2Market data

• Sep 4, 2026

  $87.90-2.02%

  DXCM fell 2.02% on below-average volume [2], a larger decline than the comparable Surgical & Medical Instruments & Apparatus companies, which moved -0.28% on average [1].

  • 1Peer group
  • 2Market data

Closing prices for DXCM. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.